sb 203580 has been researched along with sb-505124 in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (sb-505124) | Trials (sb-505124) | Recent Studies (post-2010) (sb-505124) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 22 | 0 | 15 |
Protein | Taxonomy | sb 203580 (IC50) | sb-505124 (IC50) |
---|---|---|---|
Receptor-interacting serine/threonine-protein kinase 2 | Homo sapiens (human) | 0.685 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0438 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.0438 | |
Activin receptor type-1B | Homo sapiens (human) | 0.07 | |
TGF-beta receptor type-1 | Homo sapiens (human) | 0.062 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.668 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.6072 | |
TGF-beta receptor type-1 | Mus musculus (house mouse) | 0.0766 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
1 other study(ies) available for sb 203580 and sb-505124
Article | Year |
---|---|
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |